1. Home
  2. HBB vs STRO Comparison

HBB vs STRO Comparison

Compare HBB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$18.41

Market Cap

252.9M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$39.16

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
STRO
Founded
1904
2003
Country
United States
United States
Employees
N/A
131
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
338.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
HBB
STRO
Price
$18.41
$39.16
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$31.33
AVG Volume (30 Days)
14.2K
211.2K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$606,852,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$71.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$0.67
52 Week High
$21.84
$41.88

Technical Indicators

Market Signals
Indicator
HBB
STRO
Relative Strength Index (RSI) 39.89 64.55
Support Level $17.95 $10.50
Resistance Level $20.79 N/A
Average True Range (ATR) 1.40 3.42
MACD -0.37 -0.20
Stochastic Oscillator 11.52 63.89

Price Performance

Historical Comparison
HBB
STRO

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: